Defiron 100 mg/5 ml (IV Injection or Infusion)
5 ml ampoule: ৳ 350.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Iron sucrose |
| Company | Square pharmaceuticals plc |
Product Title
- Iron Sucrose Injection USP
Categories
- Medicine
- Parenteral Iron Preparations
Description
- Treatment of Defiron deficiency
- Rapid Defiron supply
- Patients intolerant to oral Defiron therapy
- Patients with active inflammatory bowel disease
- Chronic kidney disease patients receiving erythropoietin
- Chronic kidney disease patients not receiving erythropoietin
- Hemodialysis dependent-chronic kidney disease patients
- Peritoneal dialysis dependent-chronic kidney disease patients
- Defiron deficiency anaemia in surgical patients, blood donors, and postpartum patients
Color Options
- Brown
Dosage for Adults and Elderly
- 5-10 ml Iron Sucrose Injection (100-200 mg Iron) once to three times a week
Dosage for Children
- Limited data under study conditions, recommended not to exceed 0.15 ml Iron Sucrose Injection (3 mg Iron) per kg body weight once to three times per week
Administration
- Intravenous injection
- Infusion
Interaction
- Not studied
- Not to be administered concomitantly with oral iron preparations
Contraindications
- Evidence of Iron overload
- Known hypersensitivity to Iron Sucrose or its inactive components
- Anaemia not caused by Iron deficiency
- History of allergic disorders including asthma, eczema, anaphylaxis, liver disease, and infections
Side Effects
- Hypotension
- Cramps/leg cramps
- Nausea
- Headache
- Vomiting
- Diarrhea
- Fever
- Chest pain
- Hypertension
- Hypervolemia
- Abdominal pain
- Dyspnea
- Pneumonia
- Pruritus
- Application site reaction
- Hypersensitivity reactions
Pregnancy & Lactation
- Pregnancy Category-B
- Caution in nursing women
Precautions & Warnings
- Periodic monitoring of hematologic and haematinic parameters
- Withhold in the presence of evidence of tissue Iron overload
- Caution for hypersensitivity reactions
- Caution for hypotension
Use in Special Populations
- Pediatric Use not established
- No overall differences in safety observed between elderly and younger subjects
- Injection into dialyser
- Specific dosage for Hemodialysis Dependent-Chronic Kidney Disease Patients and Non-Dialysis Dependent-Chronic Kidney Disease Patients
Overdose Effects
- Hemosiderosis
- Symptoms include hypotension, headache, vomiting, nausea, dizziness, joint aches, paresthesia, abdominal and muscle pain, edema, and cardiovascular collapse
- Treatment with IV fluids, hydrocortisone, and/or antihistamines
Therapeutic Class
- Haematinic
Storage Conditions
- Cool and dry place (15°C-30°C)
- Protected from light
- Do not freeze